Anavex Life Sciences (AVXL) has a market capitalization of $723.9M, based on 85.06M shares at a price of $8.51 (up 8.1% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
April 2025 | $8.02 | 1,715,663 | 85,064,203 | $682,214,908.06 |
March 2025 | $8.58 | 22,777,221 | 84,806,000 | $727,635,480.00 |
February 2025 | $7.91 | 20,090,890 | 84,806,000 | $670,815,460.00 |
January 2025 | $9.27 | 36,683,953 | 84,806,000 | $786,151,620.00 |
December 2024 | $10.74 | 45,842,586 | 84,806,000 | $910,816,440.00 |
November 2024 | $9.46 | 35,207,424 | 84,806,000 | $802,264,760.00 |
October 2024 | $6.62 | 17,391,404 | 84,806,000 | $561,415,720.00 |
September 2024 | $5.68 | 15,483,617 | 84,795,500 | $481,638,440.00 |
August 2024 | $6.02 | 16,756,973 | 84,795,500 | $510,468,910.00 |
July 2024 | $6.80 | 26,650,286 | 84,795,500 | $576,185,422.50 |
June 2024 | $4.22 | 26,256,952 | 84,535,300 | $356,738,966.00 |
May 2024 | $4.06 | 23,010,445 | 84,535,300 | $343,213,318.00 |
April 2024 | $3.65 | 27,559,028 | 84,535,300 | $308,553,845.00 |
March 2024 | $5.09 | 29,319,639 | 82,464,200 | $419,742,778.00 |
February 2024 | $5.14 | 24,777,523 | 82,464,200 | $423,865,988.00 |
January 2024 | $5.97 | 36,632,318 | 82,464,200 | $492,311,274.00 |
December 2023 | $9.31 | 27,594,597 | 82,077,800 | $764,144,318.00 |
November 2023 | $7.21 | 24,103,202 | 82,077,800 | $591,780,938.00 |
October 2023 | $5.58 | 19,047,024 | 82,077,800 | $457,994,124.00 |
September 2023 | $6.55 | 19,898,787 | 79,787,600 | $522,608,780.00 |
August 2023 | $7.90 | 19,328,883 | 79,787,600 | $630,322,040.00 |
July 2023 | $8.25 | 13,031,374 | 79,787,600 | $658,247,700.00 |
June 2023 | $8.13 | 24,387,542 | 80,875,200 | $657,515,376.00 |
May 2023 | $9.24 | 18,782,027 | 80,875,200 | $747,286,848.00 |
April 2023 | $8.14 | 16,866,691 | 80,875,200 | $658,324,128.00 |
